Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.43 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6659142 | 0.91 | SRD5A2 (0.65) | SRD5A2ALDH1A1FOLH1 | |
| SCHEMBL4541127 | 0.91 | ALDH1A1 (0.61) | SRD5A2LMNAMAPTHPGDHTT | |
| SCHEMBL15025047 | 0.91 | SRD5A2 (0.41) | SRD5A2LMNAMAPTHPGDESR1 | |
| SCHEMBL8091787 | 0.89 | IDO1 (0.67) | SRD5A2LMNAMAPTHPGDIDO1 | |
| SCHEMBL14234617 | 0.84 | CES2 (0.50) | IDO1FOLH1KMT2A | |
| SCHEMBL9182557 | 0.84 | ALDH1A1 (0.70) | LMNAMAPTHPGDHTTALDH1A1 | |
| SCHEMBL21514041 | 0.84 | ALDH1A1 (0.36) | SRD5A2LMNAMAPTHPGDESR1 | |
| SCHEMBL9187486 | 0.84 | MAPK13 (0.44) | SRD5A2LMNAHPGDHTTIDO1 | |
| SCHEMBL315781 | 0.82 | ALDH1A1 (0.60) | SRD5A2MAPTALDH1A1FOLH1KMT2A | |
| SCHEMBL9186881 | 0.81 | ALDH1A1 (0.42) | SRD5A2LMNAMAPTHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110027195-A1 | COMPOSITION FOR DENTAL BARRIER COMPRISING AT LEAST ONE MONOMER, AT LEAST ONE POLYMERIZATION INITIATING SYSTEM, AND AT LEAST ONE INDICATOR ENABLING THE POLYMERIZATION REACTION TO BE MONITORED | PRODUITS DENTAIRES PIERRE ROLLAND (FR) | 2011-02-03 | — | — | US | disclosed |
| US-7700375-B2 | Fluorescent labeling of specific protein targets in vitro and in vivo | VALORISATION-RECHERCHE, LP (CA) | 2010-04-20 | — | — | US | disclosed |
| US-20060147948-A1 | Fluorescent labeling of specific protein targets in vitro and in vivo | UNIVERSITY OF OTTAWA (CA) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147948-A1 | Fluorescent labeling of specific protein targets in vitro and in vivo | QPCTL, MRPL21, STAMBP | SRD5A2 4652/4885LMNA 1148/4885MAPT 1791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.